Literature DB >> 24382446

Markers of epithelial-mesenchymal transition in renal cell carcinoma.

Y V Dumanskiy1, A G Kudriashov1, I V Vasilenko2, R B Kondratyuk2, Y K Gulkov2, R S Cyrillichystiakov3.   

Abstract

AIM: To study the influence of markers of epithelial-mesenchymal transition (EMT) on a renal cell carcinoma (RCC) prognosis.
METHODS: The surgical material of 47 RCC patients who underwent nephrectomy was studied. RCC patients were distributed in two groups: a short-term survival group (3-6 months) and a long-term survival group (17-24 months). EMT markers expression was assessed by immunohistochemical methods.
RESULTS: It was determined that the rate of spindle-cell EMT was 96.4% in a short-term survival group and 42.1% in a long-term survival group. High rate Furhman's nuclear atypia, i.e. degree 3-4 occurred in 100% of cases in a short-term survival group versus 68.4% in a long-term survival group.
CONCLUSION: The rate of spindle-cell EMT in RCC may serve a more sensible prognostic factor than the degree of Furhman's nuclear atypia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24382446

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  7 in total

1.  Knockdown of sodium-calcium exchanger 1 induces epithelial-to-mesenchymal transition in kidney epithelial cells.

Authors:  Sona Lakshme Balasubramaniam; Anilkumar Gopalakrishnapillai; Nicholas J Petrelli; Sonali P Barwe
Journal:  J Biol Chem       Date:  2017-05-26       Impact factor: 5.157

2.  Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma.

Authors:  Ruriko Honda-Takinami; Kei Ishibashi; Akifumi Onagi; Ryo Tanji; Kanako Matsuoka; Seiji Hoshi; Tomoyuki Koguchi; Junya Hata; Michihiro Yabe; Yuichi Sato; Hidenori Akaihata; Masao Kataoka; Soichiro Ogawa; Nobuhiro Haga; Yoshiyuki Kojima
Journal:  IJU Case Rep       Date:  2020-01-10

Review 3.  Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

Authors:  Tim N Beck; Adaeze J Chikwem; Nehal R Solanki; Erica A Golemis
Journal:  Physiol Genomics       Date:  2014-08-05       Impact factor: 3.107

Review 4.  Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy.

Authors:  Francesco Piva; Matteo Giulietti; Matteo Santoni; Giulia Occhipinti; Marina Scarpelli; Antonio Lopez-Beltran; Liang Cheng; Giovanni Principato; Rodolfo Montironi
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

5.  Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal.

Authors:  Muyun Wei; Shaowei Mao; Guoliang Lu; Liang Li; Xiaopeng Lan; Zhongxian Huang; Yougen Chen; Miaoqing Zhao; Yueran Zhao; Qinghua Xia
Journal:  BMC Cancer       Date:  2018-04-17       Impact factor: 4.430

6.  MicroRNA‑320a suppresses tumour cell proliferation and invasion of renal cancer cells by targeting FoxM1.

Authors:  Shiyue Zhao; Yangwei Wang; Yan Lou; Yonggang Wang; Jing Sun; Manyu Luo; Wen Li; Lining Miao
Journal:  Oncol Rep       Date:  2018-07-25       Impact factor: 3.906

Review 7.  Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma.

Authors:  Prashanth Prithviraj; Nuzhat Ahmed; Revati Sharma; Elif Kadife; Mark Myers; George Kannourakis
Journal:  J Exp Clin Cancer Res       Date:  2021-06-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.